Press Releases

Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.

New Regulatory Framework for Biopharma Manufacturing in Europe Announced

Wednesday, September 03, 2025

European regulators unveil new guidelines to enhance biopharma manufacturing standards

Vyriad and Weizmann Institute of Science Enter Exclusive License Agreement for In Vivo Gene Delivery Technology

Wednesday, September 03, 2025

Vyriad Inc a clinicalstage biotechnology company developing targeted genetic therapies for cancer and other serious diseases and Yeda Research and Development Company Ltd the commercial arm of the Weizmann

Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business

Wednesday, September 03, 2025

Thermo Fisher Scientific Incthe world leader in serving science today announced the completion of its acquisition of the Purification Filtration business of Solventum NYSE SOLV for approximately billion

European Pharmaceutical Company Announces Strategic Partnership to Enhance R&D Capabilities

Tuesday, September 02, 2025

A leading European pharmaceutical company has formed a strategic alliance to bolster its research and development capabilities

Major Investment in Biosimilars Production Announced by Leading Biopharma Firm

Tuesday, September 02, 2025

A leading biopharma company has announced a substantial investment in the production of biosimilars to meet growing market demands

Eppendorf unveils next-generation pipettes delivering enhanced adaptability, precision, and comfort

Tuesday, September 02, 2025

Eppendorf today announced the worldwide sales start of its next generation of mechanical pipettes the Eppendorf Research neo The new pipettes offer renowned Eppendorf accuracy and precision

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

Monday, September 01, 2025

Rocheand Alnylam Nasdaq ALNY today announced the decision to initiate a Phase III cardiovascular outcomes trial CVOT to evaluate the ability of zilebesiran a RNAi therapeutic to reduce the risk

SmartLabs and Sonrai Launch Exclusive Partnership to Bring Advanced AI Capabilities to SmartLabs' Member Companies

Friday, August 29, 2025

SmartLabs and Sonrai Analytics Sonrai today announced a global strategic partnership designed to bring Sonrais nextgeneration AI capabilities directly into SmartLabs network of advanced research centers

Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK

Friday, August 29, 2025

Camurustoday announced that the UK Medicines and Healthcare products Regulatory Agency MHRA has approved Oczyesa octreotide subcutaneous depot marketing authorization for the maintenance treatment

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

Thursday, August 28, 2025

Pfizer Incand BioNTech SE today announced the US Food and Drug Administration FDA has approved the supplemental Biologics License Application sBLA for the companies LPadapted monovalent COVID vaccine